Trial intelligence / Profile preview

Brimonidine tartrate for injection-related erythema after Plegridy injection

2015-002159-89Phase 4Terminated

Sponsor
Biogen
Start
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of brimonidine, sponsored by Biogen. Started Aug 2015; status: terminated.

02

Drugs

brimonidine

Beyond the preview

Go deeper on 2015-002159-89.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-002159-89.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call